Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000306 · ClinicalTrials.gov registry record · Phase 2
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00000306 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 140 participants.
The verdict
NCT00000306, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
Interventions
- DRUG Dextroamphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 1994-09 |
| Est. Completion | 2001-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000306
The ClinicalTrials.gov registry entry for NCT00000306 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dextroamphetamine is the first listed.
NCT00000306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000306 about?
NCT00000306 is a clinical study titled "Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3". The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
What is the current status of trial NCT00000306?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 1994-09. Estimated completion is 2001-09.
What interventions are being tested in trial NCT00000306?
The interventions under investigation include: Dextroamphetamine (DRUG).
Who is sponsoring clinical trial NCT00000306?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.